Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
about
Role of retinoids in the prevention and treatment of colorectal cancerRetinoids modulate thioacetamide-induced acute hepatotoxicityLipid droplet binding thalidomide analogs activate endoplasmic reticulum stress and suppress hepatocellular carcinoma in a chemically induced transgenic mouse model.Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.The Expression of Bone Morphogenetic Protein 2 and Matrix Metalloproteinase 2 through Retinoic Acid Receptor Beta Induced by All-Trans Retinoic Acid in Cultured ARPE-19 Cells.Hepatic stellate cells in liver development, regeneration, and cancer.Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinomaAcyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis.Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice.Non-alcoholic steatohepatitis-related liver tumorigenesis is suppressed in mice lacking hepatic retinoid storage.Preventive effects of astaxanthin on diethylnitrosamine-induced liver tumorigenesis in C57/BL/KsJ-db/db obese mice.Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice.Preventive Effects of Vitamin C on Diethylnitrosamine-induced Hepatotoxicity in Smp30 Knockout Mice.Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanoma.Pharmacokinetic variations of tetramethylpyrazine phosphate after oral administration in hepatic precancerous mice and its hepatoprotective effects
P2860
Q26781463-D888A3A7-C94D-494F-995F-B98C9880A145Q33779952-07172A86-0220-4AA2-9644-9672B4A9CEC0Q34463693-0403C964-D686-443E-A8E6-E43166279339Q35447135-66109195-00DC-4774-8F2F-B6E486F15ACCQ35954024-9B4E46DE-AE7B-4137-8C62-70BB4ED68DB3Q36793474-A3E01778-70D0-442B-8E03-993E3757611AQ37349092-D3E43473-BAE4-412F-A918-365B488EA755Q38066478-2447A4B6-01B4-49A8-B873-CB45E2211A14Q41709525-3DDE30D9-90FD-4D17-9E3E-F03D135C2D52Q42378466-21F2B818-4EC2-4535-B772-E69EE9E2FBE5Q42479379-BD9305C2-227B-4C72-9C06-0DE9CB51D78CQ45874584-099C57FD-A8D1-41F1-9583-C51202354188Q47257473-C36D8056-F93C-4219-BDBA-F9E9C5B11E41Q53072601-51E9BA03-BF3C-49EA-8A43-3AD88C88FAC8Q57154474-09B34F3E-85EC-4A38-8F17-340EEF1620EC
P2860
Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Diethylnitrosamine-induced hep ...... ter carcinogen administration.
@ast
Diethylnitrosamine-induced hep ...... ter carcinogen administration.
@en
type
label
Diethylnitrosamine-induced hep ...... ter carcinogen administration.
@ast
Diethylnitrosamine-induced hep ...... ter carcinogen administration.
@en
prefLabel
Diethylnitrosamine-induced hep ...... ter carcinogen administration.
@ast
Diethylnitrosamine-induced hep ...... ter carcinogen administration.
@en
P2093
P2860
P356
P1433
P1476
Diethylnitrosamine-induced hep ...... ter carcinogen administration.
@en
P2093
Max E Gottesman
William S Blaner
Yohei Shirakami
P2860
P304
P356
10.1093/CARCIN/BGR275
P407
P577
2011-11-24T00:00:00Z